Congratulations! You now have unlimited access to all articles from The Analytical Scientist.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
Analysis of drug panels in urine samples can be challenging, and the trend towards larger panels including multiple drug classes compounds the issues faced during method development.
This white paper examines a number of aspects of sample preparation, and their impact on the success of subsequent LC-MS/MS analysis of broad urine panels.
Read the full article now
Log in or register to read this article in full and gain access to
The Analytical Scientist’s entire content archive. It’s FREE!
Login
Receive content, products, events as well as relevant industry updates from The Analytical Scientist and its sponsors.
